Updates to the Health Technology Assessment Policy and Methods Review including consultation 1 responses published

23 August 2023 - Responses to the first public consultation for the HTA Review (Consultation 1) have now been published ...

Read more →

Recommendations made by the PBAC (July 2023)

18 August 2023 - Recommendations made by the PBAC in July 2023 relating to the listing of medicines on the ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (August 2023)

14 August 2023 - Additional documents are now available. ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (July 2023)

2 August 2023 - Multiple new documents are now available. ...

Read more →

DoH publishes agenda for November 2023 PBAC meeting

26 July 2023 - The agenda for the November 2023 PBAC meeting is now available. ...

Read more →

DoH publishes revised agenda (version 4) for July 2023 PBAC meeting

18 July 2023 - The DoH has chosen to publish another version after the event. ...

Read more →

Public summary documents (first time decisions not to recommend and deferrals) – March 2023 PBAC meeting

14 July 2023 - The public summary documents (first time decisions not to recommend and deferrals) from the March 2023 PBAC ...

Read more →

Recommendations made out of session by the PBAC March 2023 and July 2023 meetings – changes to MS-2 Step PBS listing

11 July 2023 - In an out of session consideration, the PBAC has recommended changes to the restriction criteria and eligible ...

Read more →

Public summary documents – March 2023 PBAC meeting

30 June 2023 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the March 2023 PBAC ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee

30 June 2023 - More documents are now available. ...

Read more →

2023-24 cost recovery implementation statement for listing medicines on the PBS and designated vaccines on the NIP

28 June 2023 - 2023-24 Pharmaceutical Benefits Scheme and National Immunisation Program cost recovery fees commence on 1 July 2023. ...

Read more →

Changes to PBS eligibility criteria for Paxlovid

23 June 2023 - In an out of session consideration, the PBAC has recommended changes to the circumstances under which nirmatrelvir ...

Read more →

Outcomes of the May 2023 PBAC intracycle meeting

16 June 2023 - The outcomes from the May 2023 PBAC intracycle meeting are now available. ...

Read more →

Updates from the Health Technology Assessment Policy and Methods Review Reference Committee (June 2023)

9 June 2023 - The following documents are now available: ...

Read more →

Is the quality of evidence in health technology assessment deteriorating over time? A case study on cancer drugs in Australia.

18 May 2023 - This study aimed to assess whether there have been changes in the quality of clinical evidence ...

Read more →